Published in Psychopharmacology (Berl) on January 01, 1994
Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) (2011) 1.77
Relapse of depression after rapid depletion of tryptophan. Lancet (1997) 2.61
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry (2000) 2.25
Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology (2003) 2.14
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11
Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage (1999) 1.65
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet (1990) 1.61
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) (2002) 1.56
Brain 5-HT neurotransmission during paroxetine treatment. Br J Psychiatry (1998) 1.48
Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy. Br J Psychiatry (1992) 1.48
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry (2004) 1.45
A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol (2007) 1.43
The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis. Mol Psychiatry (2012) 1.40
Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine. Br J Psychiatry (1997) 1.40
Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep (1988) 1.39
Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism? Lancet (1982) 1.39
Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol (2008) 1.34
Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ (1993) 1.29
Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology (Berl) (2003) 1.28
Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology (1994) 1.26
'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients. Psychol Med (2008) 1.23
Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology (1994) 1.14
Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl) (1999) 1.12
Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med (2012) 1.09
Unusual interactions of benzodiazepine receptor antagonists. Nature (1982) 1.08
Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl) (2001) 1.08
The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) (1999) 1.07
Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med (1990) 1.07
Studies on the post-ictal rise in seizure threshold. Eur J Pharmacol (1981) 1.05
Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness. Psychopharmacology (Berl) (2001) 1.04
Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry (2001) 1.04
Cortisol, serotonin and depression: all stressed out? Br J Psychiatry (2002) 1.03
Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects. J Psychopharmacol (1996) 1.03
The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology (Berl) (1987) 1.02
Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry (1995) 1.02
Atenolol reduces plasma melatonin concentration in man. Br J Clin Pharmacol (1983) 1.01
Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study. Psychol Med (2009) 1.01
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage (2010) 1.00
Not fade away: the HPA axis and depression. Psychol Med (2010) 0.99
The development and use of standardized assessment of abnormal personality. Psychol Med (1981) 0.98
SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex. Mol Psychiatry (2011) 0.98
Ethyl beta-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats. Nature (1981) 0.97
Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med (1993) 0.97
Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues. Lancet (1983) 0.96
Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry (1999) 0.96
5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology (Berl) (1997) 0.95
On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock. Neuropharmacology (1980) 0.95
Direct effects of diazepam on emotional processing in healthy volunteers. Psychopharmacology (Berl) (2008) 0.93
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study. Mol Psychiatry (2012) 0.93
A cognitive neuropsychological model of antidepressant drug action. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology (Berl) (2001) 0.93
Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology (Berl) (2003) 0.93
Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study. Br J Psychiatry (2002) 0.93
Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635. Nucl Med Biol (2000) 0.93
The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study. Mol Psychiatry (2007) 0.92
Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology (Berl) (1990) 0.92
Plasma concentrations of tryptophan and dieting. BMJ (1990) 0.92
Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology (Berl) (2002) 0.91
Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol (1999) 0.91
Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors? Psychopharmacology (Berl) (1989) 0.91
Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology (Berl) (2008) 0.91
The effects of gepirone on neuroendocrine function and temperature in humans. Psychopharmacology (Berl) (1990) 0.90
Why is dieting so difficult. Nature (1995) 0.90
Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss. J Affect Disord (1990) 0.90
Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock. Neuropharmacology (1982) 0.90
Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search. Psychopharmacology (Berl) (1995) 0.90
Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry (1999) 0.89
Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berl) (2000) 0.89
Effects of a branched-chain amino acid drink in mania. Br J Psychiatry (2003) 0.89
Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology (1992) 0.89
Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry (2000) 0.89
Early effects of mirtazapine on emotional processing. Psychopharmacology (Berl) (2008) 0.88
Decreased 5-HT-mediated prolactin release in major depression. Br J Psychiatry (1992) 0.88
Electrode placement in ECT: cognitive effects. Psychol Med (1990) 0.88
Case-control study of evening melatonin concentration in primary insomnia. BMJ (1996) 0.88
Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Neuropharmacology (1980) 0.88
p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology (Berl) (1994) 0.88
Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology (Berl) (1992) 0.87
Decreased regional gray matter volume in S' allele carriers of the 5-HTTLPR triallelic polymorphism. Mol Psychiatry (2010) 0.87
Does metergoline selectively attenuate 5-HT mediated prolactin release? Psychopharmacology (Berl) (1991) 0.87
Ondansetron and opiate craving. A novel pharmacological approach to addiction. Br J Psychiatry (1995) 0.87
The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal. Br J Pharmacol (1983) 0.87
Nefazodone--a novel antidepressant--may increase REM sleep. Biol Psychiatry (1992) 0.86
Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers. Psychopharmacology (Berl) (1993) 0.86
Metergoline abolishes the prolactin response to buspirone. Psychopharmacology (Berl) (1990) 0.86
Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. J Psychopharmacol (1988) 0.86
Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. Br J Pharmacol (1998) 0.86
Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br J Pharmacol (1999) 0.86
Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. Eur J Pharmacol (1990) 0.86
Sertraline treatment does not increase plasma prolactin levels in healthy subjects. Psychopharmacology (Berl) (1998) 0.86
Modelling a loss event: effect of imagined bereavement on the hypothalamic-pituitary-adrenal axis. Psychol Med (2000) 0.85
Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology (Berl) (1993) 0.85
The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychol Med (2003) 0.84
The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task-measuring neuromodulatory effects of psychotropic drugs in man. Eur J Neurosci (1992) 0.84
SSRI treatment decreases prolactin and hyperthermic responses to mCPP. Psychopharmacology (Berl) (1997) 0.84
The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making. Psychopharmacology (Berl) (2005) 0.84
Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology (1992) 0.84
Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline? J Psychopharmacol (2013) 0.84